High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-β1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways

Journal of Cellular Physiology

Volumn 224, Issue 1, 2010, Pages 59-70

  Jung, Min Ryu ^a   Min, Young Lee ^a   Seung, Pil Yun ^a   Ho, Jae Han ^a  

^a Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BISINDOLYLMALEIMIDE; CALCIUM ION; CYCLIN D1; CYCLIN E; GLUCOSE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P42; PROTEIN P44; SMALL INTERFERING RNA; STAUROSPORINE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; CCND1 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; RECOMBINANT PROTEIN; SIGNAL PEPTIDE;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING; CALCIUM SIGNALING; CELL CULTURE; CELL CYCLE; CYTOLOGY; DNA REPLICATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FETUS BLOOD; GENETICS; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE; TIME;

MAMMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CALCIUM SIGNALING; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; CYCLIN E; DNA REPLICATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FETAL BLOOD; GLUCOSE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77952515152     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22091     Document Type: Article

References (65)

1. Barry FP, Murphy JM. 2004. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
2. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. 1990. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515-524. (Pubitemid 120034915)
3. Bertolino P, Deckers M, Lebrin F, ten Dijke P. 2005. Transforming growth factor-β signal transduction in angiogenesis and vascular disorders. Chest 128:585S-590S.
4. Bianco P, Riminucci M, Gronthos S, Robey PG. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192. (Pubitemid 32524539)
5. Bieback K, Kern S, Kluter H, Eichler H. 2004. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625-634. (Pubitemid 39014578)
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
7. Brett CM, Washington CB, Ott RJ, Gutierrez MM, Giacomini KM. 1993. Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush border membrane vesicles from human kidney. Pharm Res 10:423-426.
8. Carafoli E, Santella L, Branca D, Brini M. 2001. Generation, control and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 36:107-260. (Pubitemid 32452513)
9. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. 1980. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56:289-301. (Pubitemid 10043431)
10. Chen D, Zhao M, Mundy GR. 2004. Bone morphogenetic proteins. Growth Factors 22:233-241.
11. Cheng SL, Yang JW, Rifas L. 1994. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286.
12. Chuang CC, Yang RS, Tsai KS, Ho FM, Liu SH. 2007. Hyperglycemia enhances adipogenic induction of lipid accumulation: Involvement of extracellular signal-regulated protein kinase 1/2 phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor γ signaling. Endocrinology 148:4267-4275.
13. Dufourny B, Alblas J, van Teeffelen HA, van Schaik FM, van der Burg B, Steenbergh PH, Sussenbach JS. 1997. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem 272:31163-31171.
14. Ezeamuzie CI, Taslim N. 2008. Protein kinase C- and reactive oxygen species-dependent stimulation of intracellular cAMP in human eosinophils. The role of extracellular signal-regulated protein kinases. Med Princ Pract 17:468-474.
15. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, Shih YH, Ko MH, Sung MS. 2006. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for Parkinsonism. Stem Cells 24:115-124.
16. Fujita H, Omori S, Ishikura K, Hida M, Awazu M. 2004. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-β expression in renal tubular cells. Am J Physiol Renal Physiol 286:F120-F126. (Pubitemid 38045049)
17. Gorelik L, Flavell RA. 2002. Transforming growth factor-β in T-cell biology. Nat Rev Immunol 2:46-53. (Pubitemid 37328775)
18. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P. 2003. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12:817-828.
19. Ha H, Yu MR, Lee HB. 2001. High glucose-induced PKC activation mediates TGF-β 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59:463-470.
20. Hashemolhosseini S, Nagamine Y, Morley SJ, Desrivieres S, Mercep L, Ferrari S. 1998. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem 273:14424-14429.
21. Hochegger K, Partik G, Schorkhuber M, Marian B. 1999. Protein-kinase-C iso-enzymes support DNA synthesis and cell survival in colorectal-tumor cells. Int J Cancer 83:650-656.
22. Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, Park HK, Han H, Kim H. 2005. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun 330:1153-1161.
23. Hutson EL, Boyer S, Genever PG. 2005. Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood. Tissue Eng 11:1407-1420.
24. Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, Taghikhani M, Soleimani M. 2006. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 340:639-647.
25. Kanda S, Hodgkin MN, Woodfield RJ, Wakelam MJ, Thomas G, Claesson-Welsh L. 1997. Phosphatidylinositol 30-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J Biol Chem 272:23347-23353.
26. Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines. Blood 91:561-569.
27. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. 2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.
28. 2 and peroxisome proliferator-activated receptor δ promote mouse embryonic stem cell proliferation. Stem Cells 26:745-755.
29. Kim YH, Han HJ. 2008b. Synergistic effect of high glucose and ANG II on proliferation of mouse embryonic stem cells: Involvement of PKC and MAPKs as well as AT1 receptor. J Cell Physiol 215:374-382.
30. Kim SJ, Park K, Koeller D, Kim KY, Wakefield LM, Sporn MB, Roberts AB. 1992. Post-transcriptional regulation of the human transforming growth factor-β 1 gene. J Biol Chem 267:13702-13707.
31. Kim YH, Heo JS, Han HJ. 2006. High glucose increase cell cycle regulatory proteins level of mouse embryonic stem cells via PI3-K/Akt and MAPKs signal pathways. J Cell Physiol 209:94-102.
32. Knippenberg M, Helder MN, Doulabi BZ, Semeins CM, Wuisman PI, Klein-Nulend J. 2005. Adipose tissue-derived mesenchymal stem cells acquire bone cell-like responsiveness to fluid shear stress on osteogenic stimulation. Tissue Eng 11:1780-1788.
33. Koya D, King GL. 1998. Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866.
34. Leask A, Abraham DJ. 2004. TGF-β signaling and the fibrotic response. FASEB J 18:816-827.
35. 2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-κB signal pathways in renal proximal tubule cells. Am J Physiol Renal Physiol 294:F534-F541.
36. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669-1675.
37. Li YM, Schilling T, Benisch P, Zeck S, Meissner-Weigl J, Schneider D, Limbert C, Seufert J, Kassem M, Schutze N, Jakob F, Ebert R. 2007. Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 363:209-215. (Pubitemid 47430115)
38. Lindschau C, Quass P, Menne J, Guler F, Fiebeler A, Leitges M, Luft FC, Haller H. 2003. Glucose-induced TGF-β1 and TGF-β receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha. Hypertension 42:335-341.
39. Lukas J, Lukas C, Bartek J. 2004. Mammalian cell cycle checkpoints: Signalling pathways and their organization in space and time. DNA Repair (Amst) 3:997-1007.
40. Luo J, Manning BD, Cantley LC. 2003. Targeting the PI3K-Akt pathway in human cancer: Rationale and promise. Cancer Cell 4:257-262.
41. 2+ channels in human glomerular mesangial cells. Am J Physiol Cell Physiol 283: C1390-C1398.
42. Mackman N, Brand K, Edgington TS. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor k B binding sites. J Exp Med 174:1517-1526.
43. Mateo-Lozano S, Tirado OM, Notario V. 2003. Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation. Oncogene 22:9282-9287.
44. Murray AW. 2004. Recycling the cell cycle: Cyclins revisited. Cell 116:221-234.
45. Nathan C, Sporn M. 1991. Cytokines in context. J Cell Biol 113:981-986.
46. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
47. Pellegatta F, Chierchia SL, Zocchi MR. 1998. Functional association of platelet endothelial cell adhesion molecule-1 and phosphoinositide 3-kinase in human neutrophils. J Biol Chem273: 27768-27771.
48. Rahimi RA, Andrianifahanana M, Wilkes MC, Edens M, Kottom TJ, Blenis J, Leof EB. 2009. Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-β. Cancer Res 69:84-93.
49. Raught B, Gingras AC. 1999. eIF4E activity is regulated at multiple levels. Int J Biochem Cell Biol 31:43-57.
50. Sakamoto N, Sugimura K, Kawashima H, Tsuchida K, Takemoto Y, Naganuma T, Tatsumi S, Nakatani T. 2005. Influence of glucose and inflammatory cytokines on TGF-β1 and CTGF mRNA expressions in human peritoneal mesothelial cells. Int J Mol Med 15:907-911.
51. Satija NK, Gurudutta GU, Sharma S, Afrin F, Gupta P, Verma YK, Singh VK, Tripathi RP. 2007. Mesenchymal stem cells: Molecular targets for tissue engineering. Stem Cells Dev 16:7-23.
52. Sherr CJ. 1995. Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Physicians 107:181-186.
53. Sherr CJ. 2000. Cell cycle control and cancer. Harvey Lect 96:73-92.
54. Sheu ML, Ho FM, Yang RS, Chao KF, Lin WW, Lin-Shiau SY, Liu SH. 2005. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol 25:539-545.
55. Shih DT, Lee DC, Chen SC, Tsai RY, Huang CT, Tsai CC, Shen EY, Chiu WT. 2005. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 23:1012-1020.
56. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. 2006. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462-471.
57. Sporn MB, Roberts AB. 1992. Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119:1017-1021.
58. Sugimoto R, Enjoji M, Kohjima M, Tsuruta S, Fukushima M, Iwao M, Sonta T, Kotoh K, Inoguchi T, Nakamuta M. 2005. High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase. Liver Int 25:1018-1026.
59. Vaananen HK. 2005. Mesenchymal stem cells. Ann Med 37:469-479.
60. van der Velden AW, Thomas AA. 1999. The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 31:87-106.
61. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW. 2004. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428:332-337.
62. Wolf G. 2006. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-β pathway. Kidney Int 70:1914-1919.
63. Wullschleger S, Loewith R, Hall MN. 2006. TOR signaling in growth and metabolism. Cell 124: 471-484.
64. Yun SP, Lee MY, Ryu JM, Song CH, Han HJ. 2009. Role of HIF-1α and VEGF in human mesenchymal stem cell proliferation by estradiol-17β: Involvement of the PKC, PI3K/Akt, and MAPKs. Am J Physiol Cell Physiol 296:C317-C326.
65. Zhang X, Mitsuru A, Igura K, Takahashi K, Ichinose S, Yamaguchi S, Takahashi TA. 2006. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 340:944-952.